These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27573706)

  • 1. Apoptosis repressor with caspase recruitment domain enhances survival and promotes osteogenic differentiation of human osteoblast cells under Zoledronate treatment.
    Hu L; Han J; Yang X; Wang Y; Pan H; Xu L
    Mol Med Rep; 2016 Oct; 14(4):3535-42. PubMed ID: 27573706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of osteoblast function in vitro by aminobisphosphonates.
    Orriss IR; Key ML; Colston KW; Arnett TR
    J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures.
    Corrado A; Neve A; Maruotti N; Gaudio A; Marucci A; Cantatore FP
    Clin Exp Rheumatol; 2010; 28(6):873-9. PubMed ID: 21205463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
    Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
    Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of zoledronate on the survival and function of human osteoblast-like cells.
    Huang KC; Cheng CC; Chuang PY; Yang TY
    BMC Musculoskelet Disord; 2015 Nov; 16():355. PubMed ID: 26572124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
    Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
    Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
    Walter C; Pabst A; Ziebart T; Klein M; Al-Nawas B
    Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
    Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
    Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
    Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
    Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
    Cui P; Liu H; Sun J; Amizuka N; Sun Q; Li M
    Histol Histopathol; 2018 Jan; 33(1):89-99. PubMed ID: 28345127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.
    Dalle Carbonare L; Mottes M; Malerba G; Mori A; Zaninotto M; Plebani M; Dellantonio A; Valenti MT
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28608802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
    Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
    Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss.
    Lindtner RA; Tiaden AN; Genelin K; Ebner HL; Manzl C; Klawitter M; Sitte I; von Rechenberg B; Blauth M; Richards PJ
    Osteoporos Int; 2014 Mar; 25(3):1151-61. PubMed ID: 23974861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
    von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
    Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pamidronate on human alveolar osteoblasts in vitro.
    Marolt D; Cozin M; Vunjak-Novakovic G; Cremers S; Landesberg R
    J Oral Maxillofac Surg; 2012 May; 70(5):1081-92. PubMed ID: 21856057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low level laser therapy and zoledronate on the viability and ALP activity of Saos-2 cells.
    Bayram H; Kenar H; Taşar F; Hasırcı V
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):140-6. PubMed ID: 22571861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo.
    Draenert GF; Huetzen DO; Kämmerer PW; Palarie V; Nacu V; Wagner W
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e369-74. PubMed ID: 22429609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
    Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
    Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.